GlassScriptPhysician profile
Kristin A Matteson
NPI 1063532125
$338.51
in general payments reported to CMS, 2019-2025
7 companies · $95.20 in 2025
The $95.20 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $12.28 · 2021: $67.15 · 2022: $17.81 · 2023: $14.58 · 2024: $131 · 2025: $95.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $144 · Education: $97.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $144.27 |
| Education | $97.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Travere Therapeutics, INC. | $207.92 | 2024-2025 | Filspari |
| Aurinia Pharma U.S., INC. | $49.69 | 2021 | |
| Csl Behring | $18.77 | 2025 | Kcentra |
| Vifor Pharma, INC. | $17.81 | 2022 | |
| Glaxosmithkline, LLC. | $17.46 | 2021 | |
| Horizon Therapeutics Plc | $14.58 | 2023 | Krystexxa |
| Akebia Therapeutics INC | $12.28 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristin Matteson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.